Functional experiments show that Osteopontin (OPN) is a positive regulator, while SPP2, LECT2, SLC10A1, CYP3A4, HSD17B13, and IYD are negative regulator for HCC glycolysis. This evidence concerns the gene HSD17B13 and hepatocellular carcinoma.